Carmen E. Demarco, MD
Infectious Disease Physician · Royal Oak, MI
Carmen E. Demarco, MD is an infectious disease physician with a practice address in Royal Oak, Michigan, and NPI 1790808616, issued on Apr 7, 2007. Check the license (Michigan 4301074802, as entered in NPPES) on the Michigan Board of Medicine (LARA); the Medicare figures below come from public CMS files.
- Name
- Carmen E. Demarco
- Credential
- MD
- Primary taxonomy
- Infectious Disease Physician 207RI0200X
- License number
- 4301074802 MI
Self-reported in NPPES; status is on the state search - Practice location
- 3535 W 13 Mile RD Ste 605, Royal Oak, MI 48073
- Phone
- (248) 551-0495
- Enumerated
- Apr 7, 2007
- Record last updated
- Jun 21, 2021 (not updated in 5 years: call before relying on the address or phone)
- Fax
- (248) 551-7268
- Medicare enrollment
- Enrolled (PECOS I20071109000605); accepts Medicare assignment
- Entity
- Type 1 · individual
Also registered at 3535 W 13 Mile RD Ste 605
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Jeffrey BandInfectious Disease Physician1346218575
- Christopher CarpenterInfectious Disease Physician1003875600
- Noora Kazanji, D.O.Infectious Disease Physician1407294507
- Carl LauterAllergy & Immunology Physician1861452567
- Lea Monday, M.D.Infectious Disease Physician1487017513
- Matthew Sims, MDInfectious Disease Physician1205851730
Verify Carmen E. Demarco in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersMichigan Board of Medicine (LARA)
Search for license 4301074802Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
56% fewer Medicare Part D claims than the average infectious disease physician in 2024
306 Medicare Part D claims for 45 beneficiaries, against an average of 689 among the 7,388 providers of this specialty who prescribed in Part D. Brand-name drugs were 10% of claims.
Most prescribed
- Ceftriaxone70 claims
- Daptomycin44 claims
- Fosfomycin Tromethamine23 claims
- Amoxicillin-Clavulanate Potass17 claims
- Ertapenem17 claims
- Vancomycin Hcl16 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 81 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $300.00
2 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 3,895 providers of this specialty with any payment received $4,362.19 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Beaumont Medical Group- Specialty ServicesFarmington Hills, MI
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Infectious Disease Physician providers in Michigan
There are 301 infectious disease physician records in Michigan.
Other infectious disease physician records in Michigan
- Mohammed Abdelhalim, MBCHBDearborn, MI1679197305
- Emily Abdoler, M.D.Ann Arbor, MI1033556410
- Hend Abdul-Jauwad, MB, BCH, BAOPlymouth, MI1205002102
- Elfatih Abter, MDLapeer, MI1255473534
- Fadi Abu Yasin, MDCanton, MI1417070590
- Syed Ahmad, M.D.Farmington Hills, MI1588819288
- Wael Al Zyud, MDRoyal Oak, MI1386568624
- Bishr Al-Ujayli, M.D.Rochester Hills, MI1790797355
- George Alangaden, MDDetroit, MI1194762799
- Owen Albin, MDAnn Arbor, MI1629414628
Common questions
What is Carmen E. Demarco, MD's NPI number?
Carmen E. Demarco, MD's National Provider Identifier (NPI) is 1790808616, issued on Apr 7, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Carmen E. Demarco, MD located?
The NPPES record lists a practice address at 3535 W 13 Mile RD Ste 605, Royal Oak, MI, 48073. Phone: (248) 551-0495. Providers update this record themselves, so call before visiting.
How can I verify Carmen E. Demarco, MD's license?
NPPES lists Michigan license number 4301074802, as entered by the provider. Search the Michigan Board of Medicine (LARA) at https://aca-prod.accela.com/MILARA/GeneralProperty/PropertyLookUp.aspx?isLicensee=Y&TabName=APO. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Carmen E. Demarco, MD prescribe under Medicare Part D?
In 2024, Carmen E. Demarco, MD had 306 Medicare Part D claims for 45 beneficiaries; the average among infectious disease physician prescribers was 689. Part D covers Medicare prescriptions only.
What is Carmen E. Demarco, MD's MIPS final score?
The 2023 MIPS final score is 81 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.